Vaginal odorants

Use of at least one vaginal odorant compound selected from the group consisting of hydrogen sulfide, methylpropanal, butan-2,3-dione (diacetyl), n-hexanal, n-heptanal, n-octanal, n-nonanal, 1-octen-3-one, 2-acetyl-1-pyrroline, 2-acetylpyridine, 2-acetylthiazoline, 2-acetyltetrahydropyridine, 2-acetylpyrazine, 3-methylthio propanal (methional), (Z)-non-2-enal, 3-isobutyl-2-methoxypyrazine, (E)-non-2-enal, (E)-β-damascenone, β-damascone, β3-ionone α-ionone, tr-(4,5)-epoxy-(E)-dec-2-enal, 4-hydroxy-2,5-dimethyl-3(2H)-furanone, 3-hydroxy-4,5-dimethyl-2(5H)-furanone (Sotolon), (Z)-6-γ-dodecenolactone, δ-dodecalactone, 3-methylindole (skatol), indole, 2-aminoacetophenone, phenylacetic acid, acetic acid, butanoic acid, 2/3 methylbutanoic acid, phenylacetaldehyde and vanillin for mimicking or imitating vaginal smell.

Use of at least one vaginal odorant compound selected from the group consisting of hydrogen sulfide, methylpropanal, butan-2,3-dione (diacetyl), n-hexanal, n-heptanal, n-nonanal, 1-octen-3-one, 2-acetyl-1-pyrroline, 2-acetylpyridine, 2-acetylthiazoline, 2-acetyltetrahydropyridine, 2-acetylpyrazine, 3-methylthio propanal (methional), (Z)-non-2-enal, 3-isobutyl-2-methoxypyrazine, (E)-non-2-enal, phenylacetaldehyde, (E)-β-damascenone, β-damascone, β-ionone α-ionone, tr-(4,5)-epoxy-(E)-dec-2-enal, 4-hydroxy-2,5-dimethyl-3(2H)-furanone, 3-hydroxy-4,5-dimethyl-2(5H)-furanone (Sotolon), (Z)-6-γ-dodecenolactone, δ-dodecalactone, 3-methylindole (skatol), indole, 2-aminoacetophenone, phenylacetic acid, and vanillin for the manufacture of a pharmaceutical composition for treatment of reduced fertility of males and/or females.

Use of at least one vaginal odorant compound selected from the group consisting of hydrogen sulfide, methylpropanal, butan-2,3-dione (diacetyl), n-hexanal, n-heptanal, n-nonanal, 1-octen-3-one, 2-acetyl-1-pyrroline, 2-acetylpyridine, 2-acetylthiazoline, 2-acetyltetrahydropyridine, 2-acetylpyrazine, 3-methylthio propanal (methional), (Z)-non-2-enal 3-isobutyl-2-methoxypyrazine, (E)-non-2-enal, phenylacetaldehyde, (E)-β-damascenone, β-damascone, (3-ionone α-ionone, tr-(4,5)-epoxy-(E)-dec-2-enal, 4-hydroxy-2,5-dimethyl-3(2H)-furanone, 3-hydroxy-4,5-dimethyl-2(5H)-furanone (Sotolon), (Z)-6-γ-dodecenolactone, δ-dodecalactone, 3-methylindole (skatol), indole, 2-aminoacetophenone, phenylacetic acid, and vanillin for the manufacture of a contraceptive.

Article for vaginal use comprising at least one vaginal odorant compound selected from the group consisting of hydrogen sulfide, methylpropanal, butan-2,3-dione (diacetyl), n-hexanal, n-heptanal, n-nonanal, 1-octen-3-one, 2-acetyl-1-pyrroline, 2-acetylpyridine, 2-acetylthiazoline, 2-acetyltetrahydropyridine, 2-acetylpyrazine, 3-methylthio propanal (methional), (Z)-non-2-enal, 3-isobutyl-2-methoxypyrazine, (E)-non-2-enal, phenylacetaldehyde, (E)-β-damascenone, β-damascone, (β-ionone α-ionone, tr-(4,5)-epoxy-(E)-dec-2-enal, 4-hydroxy-2,5-dimethyl-3(2H)-furanone, 3-hydroxy-4,5-dimethyl-2(5H)-furanone (Sotolon), (Z)-6-γ-dodecenolactone, δ-dodecalactone, 3-methylindole (skatol), indole, 2-aminoacetophenone, phenylacetic acid, and vanillin.

A vaginal odorant compound selected from the group consisting of hydrogen sulfide, methylpropanal, butan-2,3-dione (diacetyl), n-hexanal, n-heptanal, n-nonanal, 1-octen-3-one, 2-acetyl-1-pyrroline, 2-acetylpyridine, 2-acetylthiazoline, 2-acetyltetrahydropyridine, 2-acetylpyrazine, 3-methylthio propanal (methional), (Z)-non-2-enal, 3-isobutyl-2-methoxypyrazine, (E)-non-2-enal, phenylacetaldehyde, (E)-β-damascenone, β-damascone, β-ionone α-ionone, tr-(4,5)-epoxy-(E)-dec-2-enal, 4-hydroxy-2,5-dimethyl-3(2H)-furanone, 3-hydroxy-4,5-dimethyl-2(5H)-furanone (Sotolon), (Z)-6-γ-dodecenolactone, δ-dodecalactone, 3-methylindole (skatol), indole, 2-aminoacetophenone, phenylacetic acid, and vanillin as a medicament.